June 15, 2018
Rose
Benchling, which offers a software suite for improving collaboration and productivity among life sciences and biotech researchers, has raised $14.5 million in series B funding. Benchmark led the round, with additional participation by F-Prime Capital and returning investor Thrive Capital.
from MobiHealthNews https://ift.tt/2lcXDuQ
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment